E
Esperion Therapeutics, Inc.ESPR
Esperion Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and delivering innovative cardiometabolic and rare/orphan disease therapies. The Company leverages deep domain expertise in ACLY biology to develop and commercialize transformative medicines for patients.
US StocksHealthcareSmall CapBiotechnologyConsumer StaplesGrowth Stocks
ESPR Price Trend
Esperion Therapeutics, Inc. · Full TradingView Chart
NASDAQ:ESPR